Descriptive epidemiology of cutaneous melanoma – A treasure for generating hypotheses

por Stang, Andreas, Hauschild, Axel
Publicado 2021

Feasibility of assessing utilities with a single-item standard gamble questionnaire in patients with melanoma

por Blome, Christine, Kähler, Katharina C., Wagner, Tobias, Hauschild, Axel, Augustin, Matthias
Publicado 2021

Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

por Garbe, Claus, Eigentler, Thomas K., Keilholz, Ulrich, Hauschild, Axel, Kirkwood, John M.
Publicado 2011

Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials

por Dummer, Reinhard, Schadendorf, Dirk, Ascierto, Paolo A, Larkin, James, Lebbé, Celeste, Hauschild, Axel
Publicado 2014

Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

por Lear, John T, Hauschild, Axel, Stockfleth, Eggert, Squittieri, Nicholas, Basset-Seguin, Nicole, Dummer, Reinhard
Publicado 2020

Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives

por Middleton, Mark R., Hoeller, Christoph, Michielin, Olivier, Robert, Caroline, Caramella, Caroline, Öhrling, Katarina, Hauschild, Axel
Publicado 2020

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase

por GLUTSCH, Valerie, AMARAL, Teresa, GARBE, Claus, THOMS, Kai-Martin, MOHR, Peter, HAUSCHILD, Axel, SCHILLING, Bastian
Publicado 2020

Patterns of response with talimogene laherparepvec in combination with ipilimumab or ipilimumab alone in metastatic unresectable melanoma

por Chesney, Jason, Puzanov, Igor, Collichio, Frances, Milhem, Mohammed M., Hauschild, Axel, Chen, Lisa, Sharma, Anjali, Garbe, Claus, Singh, Parminder, Mehnert, Janice M.
Publicado 2019

The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Is Critically Involved in the Development of Cytotoxic CD8(+) T Cells in Mice and Humans

por Loser, Karin, Brzoska, Thomas, Oji, Vinzenz, Auriemma, Matteo, Voskort, Maik, Kupas, Verena, Klenner, Lars, Mensing, Cornelius, Hauschild, Axel, Beissert, Stefan, Luger, Thomas A.
Publicado 2010

Willingness to pay for a cure of low-risk melanoma patients in Germany

por Augustin, Matthias, Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Wilden, Sophia, Kähler, Katharina C.
Publicado 2018

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled a...

por Ascierto, Paolo A., Ribas, Antoni, Larkin, James, McArthur, Grant A., Lewis, Karl D., Hauschild, Axel, Flaherty, Keith T., McKenna, Edward, Zhu, Qian, Mun, Yong, Dréno, Brigitte
Publicado 2020

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians

por Kähler, Katharina C., Blome, Christine, Forschner, Andrea, Gutzmer, Ralf, Hauschild, Axel, Heinzerling, Lucie, Livingstone, Elisabeth, Loquai, Carmen, Müller-Brenne, Tina, Schadendorf, Dirk, Utikal, Jochen, Wagner, Tobias, Augustin, Matthias
Publicado 2018

Impact of depth of response on survival in patients treated with cobimetinib ± vemurafenib: pooled analysis of BRIM-2, BRIM-3, BRIM-7 and coBRIM

por Lewis, Karl D., Larkin, James, Ribas, Antoni, Flaherty, Keith T., McArthur, Grant A., Ascierto, Paolo A., Dréno, Brigitte, Yan, Yibing, Wongchenko, Matthew, McKenna, Edward, Zhu, Qian, Mun, Yong, Hauschild, Axel
Publicado 2019

Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective

por Jutzi, Tanja B., Krieghoff-Henning, Eva I., Holland-Letz, Tim, Utikal, Jochen Sven, Hauschild, Axel, Schadendorf, Dirk, Sondermann, Wiebke, Fröhling, Stefan, Hekler, Achim, Schmitt, Max, Maron, Roman C., Brinker, Titus J.
Publicado 2020

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma

por Lacouture, Mario E., Dréno, Brigitte, Ascierto, Paolo Antonio, Dummer, Reinhard, Basset-Seguin, Nicole, Fife, Kate, Ernst, Scott, Licitra, Lisa, Neves, Rogerio I., Peris, Ketty, Puig, Susana, Sokolof, Jonas, Sekulic, Aleksandar, Hauschild, Axel, Kunstfeld, Rainer
Publicado 2016

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

por Zimmer, Lisa, Vaubel, Julia, Mohr, Peter, Hauschild, Axel, Utikal, Jochen, Simon, Jan, Garbe, Claus, Herbst, Rudolf, Enk, Alexander, Kämpgen, Eckhart, Livingstone, Elisabeth, Bluhm, Leonie, Rompel, Rainer, Griewank, Klaus G., Fluck, Michael, Schilling, Bastian, Schadendorf, Dirk
Publicado 2015

Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II tria...

por Chesney, Jason A, Puzanov, Igor, Collichio, Frances A, Singh, Parminder, Milhem, Mohammed M, Glaspy, John, Hamid, Omid, Ross, Merrick, Friedlander, Philip, Garbe, Claus, Logan, Theodore, Hauschild, Axel, Lebbé, Celeste, Joshi, Harshada, Snyder, Wendy, Mehnert, Janice M
Publicado 2023

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

por Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Publicado 2015

Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?

por Mangana, Joanna, Cheng, Phil F., Schindler, Katja, Weide, Benjamin, Held, Ulrike, Frauchiger, Anna L., Romano, Emanuella, Kähler, Katharina C., Rozati, Sima, Rechsteiner, Markus, Moch, Holger, Michielin, Olivier, Garbe, Claus, Hauschild, Axel, Hoeller, Christoph, Dummer, Reinhard, Goldinger, Simone M.
Publicado 2015

The “Great Debate” at Melanoma Bridge 2022, Naples, December 1st–3rd, 2022

por Ascierto, Paolo A., Blank, Christian, Eggermont, Alexander M., Garbe, Claus, Gershenwald, Jeffrey E., Hamid, Omid, Hauschild, Axel, Luke, Jason J., Mehnert, Janice M., Sosman, Jeffrey A., Tawbi, Hussein A., Mandalà, Mario, Testori, Alessandro, Caracò, Corrado, Osman, Iman, Puzanov, Igor
Publicado 2023